SCHEMBL30206204

SCHEMBL30206204

COC(=O)c1nc(Cl)c(C)nc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.47
▸ ALDH1A1 P00352 8/20 0.38
▸ SMN1; SMN2 Q16637 7/20 0.38
▸ KDM4E B2RXH2 6/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ PKM P14618 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ NPC1 O15118 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ RCE1 Q9Y256 1/20 0.35
▸ S1PR4 O95977 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29173440 1.00 NPSR1 (0.47) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL12108293 0.83 NPSR1 (0.52) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL2408051 0.83 NPSR1 (0.52) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL30205955 0.81 NPSR1 (0.45) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL29173541 0.81 NPSR1 (0.45) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL12108294 0.80 NPSR1 (0.48) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL20302593 0.79 NPSR1 (0.52) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL31214346 0.79 NPSR1 (0.52) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL29173359 0.79 NPSR1 (0.44) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A
SCHEMBL30206069 0.79 NPSR1 (0.44) NPSR1ALDH1A1SMN1; SMN2KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
EP-4373817-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER Astrazeneca AB (SE) 2024-05-29 — — EP disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback